Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TransMedics (TMDX) Equity Ratio (2018 - 2026)

TransMedics has reported Equity Ratio over the past 8 years, most recently at 0.44 for Q4 2025.

  • For Q4 2025, Equity Ratio rose 55.76% year-over-year to 0.44; the TTM value through Dec 2025 reached 0.44, up 55.76%, while the annual FY2025 figure was 0.44, 55.76% up from the prior year.
  • Equity Ratio for Q4 2025 was 0.44 at TransMedics, up from 0.38 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.68 in Q3 2022 and troughed at 0.18 in Q3 2023.
  • A 5-year average of 0.42 and a median of 0.4 in 2022 define the central range for Equity Ratio.
  • Biggest five-year swings in Equity Ratio: tumbled 73.15% in 2023 and later soared 55.76% in 2025.
  • Year by year, Equity Ratio stood at 0.5 in 2021, then surged by 34.4% to 0.68 in 2022, then tumbled by 71.26% to 0.19 in 2023, then surged by 46.3% to 0.28 in 2024, then skyrocketed by 55.76% to 0.44 in 2025.
  • Business Quant data shows Equity Ratio for TMDX at 0.44 in Q4 2025, 0.38 in Q3 2025, and 0.36 in Q2 2025.